A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome

Abstract Background There is uncertainty regarding the safety and effectiveness of direct oral anticoagulant agents in patients with antiphospholipid syndrome (APS). We performed a multicenter feasibility study to examine our ability to identify and obtain consent from eligible APS patients and to o...

Full description

Bibliographic Details
Main Authors: Kimberly Legault, Mark Blostein, Marc Carrier, Susan Khan, Sam Schulman, Sudeep Shivakumar, Cynthia Wu, Mark A. Crowther
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Pilot and Feasibility Studies
Subjects:
Antiphospholipid syndrome
Feasibility studies
Hemorrhage
Rivaroxaban
Thromboembolism
Online Access:http://link.springer.com/article/10.1186/s40814-020-00594-1

Internet

http://link.springer.com/article/10.1186/s40814-020-00594-1

Similar Items